We introduce a new category of nanoparticle-based T 1 MRI contrast agents (CAs) by encapsulating paramagnetic chelated gadolinium(III), i.e., Gd 3þ $DOTA, through supramolecular assembly of molecular building blocks that carry complementary molecular recognition motifs, including adamantane (Ad) and b-cyclodextrin (CD). A small library of Gd 3þ $DOTA-encapsulated supramolecular nanoparticles (Gd 3þ $DOTA3SNPs)
a b s t r a c t
We introduce a new category of nanoparticle-based T 1 MRI contrast agents (CAs) by encapsulating paramagnetic chelated gadolinium(III), i.e., Gd 3þ $DOTA, through supramolecular assembly of molecular building blocks that carry complementary molecular recognition motifs, including adamantane (Ad) and b-cyclodextrin (CD). A small library of Gd 3þ $DOTA-encapsulated supramolecular nanoparticles (Gd 3þ $DOTA3SNPs)
was produced by systematically altering the molecular building block mixing ratios. A broad spectrum of relaxation rates was correlated to the resulting Gd 3þ $DOTA3SNP library. Consequently, an optimal synthetic formulation of Gd 3þ $DOTA3SNPs with an r 1 of 17.3 s À1 mM À1 (ca. 4-fold higher than clinical Gd 3þ chelated complexes at high field strengths) was identified. T 1 -weighted imaging of Gd 3þ $DOTA3SNPs exhibits an enhanced sensitivity with a contrast-to-noise ratio (C/N ratio) ca. 3.6 times greater than that observed for free Gd 3þ $DTPA. A Gd 3þ $DOTA3SNPs solution was injected into foot pads of mice, and MRI was employed to monitor dynamic lymphatic drainage of the Gd 3þ $DOTA3SNPs-based CA. We observe an increase in signal intensity of the brachial lymph node in T 1 -weighted imaging after injecting Gd 3þ $DOTA3SNPs but not after injecting Gd 3þ $DTPA. The MRI results are supported by ICP-MS analysis ex vivo. These results show that Gd 3þ $DOTA3SNPs not only exhibits enhanced relaxivity and high sensitivity but also can serve as a potential tool for diagnosis of cancer metastasis. Ó 2010 Elsevier Ltd. All rights reserved.
Introduction
Magnetic resonance imaging (MRI) is a medical imaging technique capable of three-dimensional (3D), high-resolution visualization of specific tissues or organs in the body and has been extensively used in neurological, cardiovascular, and oncological diagnosis [1e3] . Paramagnetic MRI contrast agents (CAs), usually composed of gadolinium(III) ion (Gd 3þ ), are capable of reducing the longitudinal relaxation time (T 1 ) of surrounding water protons, thus increasing signal intensity in T 1 -weighted MRI. In general, the performance of T 1 -weighted MRI CAs is determined by the relaxivity (r 1 ), which can be correlated to several parameters, including the loading capacity (Gd 3þ quantity in the intraparticular space) and the water accessibility (the distance of closest approach between water and Gd 3þ , the number of water molecules associated with Gd 3þ , and/or the diffusion of water) as described by relaxation theory [4] . Based on this fundamental understanding, researchers have incorporated Gd 3þ onto or into nanoscale carriers to enhance r 1 of paramagnetic CAs. Compared to small Gd 3þ chelated complexes alone, nanocarriers (e.g., dendrimers [5e8,12] , polymers [9, 10, 14] , liposomes [11, 13, 15, 16] , and inorganic nanoparticles (NPs)
[17e20]) allow dramatically increased Gd 3þ loading. In some cases, poor water accessibility to the intraparticular Gd 3þ buried inside the carriers can compromise the performance in T 1 -weighted MRI [21] and this challenge can be tackled by, for example, using porous nanocarriers [8, 22] where a water molecule can travel from the bulk water into the interior space. Nevertheless, fine-tuning the balance of the relevant parameters in a synergistic fashion is challenging due to the lack of direct correlations among the parameters, not to mention the unsatisfactory synthetic approach employed for the development of Gd 3þ -incorporated nanocarriers that are considered to be time-consuming and cumbersome [23] . Therefore, there is a need to establish a method capable of effective optimization of all parameters to achieve high relaxivity enhancement of T 1 -weighted MRI CAs.
Previously, we introduced a convenient, flexible, and modular self-assembly approach [24] for the preparation of supramolecular NPs (SNPs) by mixing three molecular building blocks, including an adamantane-grafted (Ad-grafted) polyamidoamine dendrimer (Ad-PAMAM), a b-cyclodextrin-grafted (CD-grafted) branched polyethylenimine (CD-PEI), and an Ad-grafted polyethylene glycol (Ad-PEG). A variety of SNPs with controllable sizes, surface chemistry, and cross-linking degree of the Ad-PAMAM/CD-PEI hydrogel network in the SNP cores were prepared. We were able to demonstrate that the uniqueness of this supramolecular synthetic approach facilitates the preparations of different SNPs for applications in PET imaging [24] , gene delivery [25, 26] , and photothermal treatment [27] . We set out to further explore such a self-assembled approach to develop Gd 3þ $DOTA-encapsulated SNPs (Gd 3þ $DOTA3SNPs, Fig. 1 $DOTA3SNPs not only exhibits enhanced relaxivity and high sensitivity but can also serve as a potential tool for diagnosis of cancer metastasis.
Materials and methods

Materials
Reagents and solvents were purchased from SigmaeAldrich (St. Louis, MO) and used as received without further purification otherwise noted. 1-Adamantanamine (Ad) hydrochloride and b-cyclodextrin (b-CD) were purchased from TCI America (San Francisco, CA). DOTA/CD-grafted branched polyethylenimine (DOTA-CD-PEI) and Ad-grafted polyethylene glycol (Ad-PEG) were prepared via the method previously reported by our group [24] . 
Synthesis of Gd
Synthesis of Gd 3þ
$DOTA3SNPs
To a 750-mL solution of Ad-PEG (9 mg/mL), various concentrations of Ad-PAMAM (22.5, 15, 11.3, 7.5 mg/mL) in 15-mL DMSO were slowly injected under vigorous stirring. A 750-mL Gd 3þ $DOTA-CD-PEI solution containing different Gd 3þ loading concentration (0.32, 0.63, 1.61, 3.22, 3.9 and 6.44 mM, verified with ICP-MS) was sequentially added into the mixture to obtain a collection of Gd 3þ $DOTA3SNPs.
Dynamic light scattering (DLS)
DLS experiments were performed with a Zetasizer Nano instrument (Malvern Instruments Ltd., United Kingdom) equipped with a 10-mW helium-neon laser (l ¼ 632.8 nm) and thermoelectric temperature controller. Measurements were taken at a 90 scattering angle. Fig. 1 . Schematic representation of self-assembly approach for preparation of Gd 3þ $DOTA-encapsulated supramolecular nanoparticles (Gd 3þ $DOTA3SNPs).
Transmission electron microscope (TEM)
The morphology and sizes of Gd 3þ $DOTA3SNPs were examined on a Philips CM 120 transmission electron microscope (TEM), operating at an acceleration voltage of 120 kV. The TEM samples were prepared by drop-coating 2 mL of Gd 3þ $DOTA3SNPs
solutions onto carbon-coated copper grids. Excess amounts of droplets were removed by filter papers after 45 s. Subsequently, the surface-deposited Gd 3þ $DOTA3SNPs were negatively stained with 2% uranyl acetate for 45 s before the TEM studies.
Zeta potential measurements
Zeta potentials of Gd 3þ $DOTA3SNPs were determined by photon correlation spectroscopy using a Zetasizer Nano instrument, (Malvern Instruments, Malvern, Worcestershire, UK). The measurements were performed at 25 C with a detection angle of 90 , and the raw data were subsequently correlated to Z average mean size using a cumulative analysis by the Zetasizer software package.
ICP-MS analysis
Samples (20 mL) were diluted to a total volume of 2.00 mL using aqueous 2% nitric acid. 20 mL of a 5-ppm aqueous indium ion solution (ICP-MS grade) was then added to each tube as an internal standard and the contents vortexted vigorously. ICP measurements were then conducted on an Agilent 7500 Series ICP-MS in helium collision gas mode. Reported measurements of gadolinium in each sample represent the average of 3 measurements, and are back-calculated to offset the initial dilution. The individual measurements are typically obtained with a relative standard deviation of approximately 3% or less per sample. Fig. 2 . A mesh plot of r 1 relaxivity performance of Gd 3þ $DOTA3SNPs with variation of (i) ratio of two molecular building blocks, i.e., Ad-PAMAM and DOTA-CD-PEI, and (ii) loading of Gd 3þ (24 data points). The peak value indicates the highest r 1 relaxivity (Gd 3þ $DOTA3SNPs with a ratio of 1:2 and at a Gd 3þ concentration of 3.9 mM). was added into a centrifugal filter at 10 K rpm for 30 min. After recovering filtrate containing free Gd 3þ and supernatant containing encapsulated Gd 3þ , the quantity of Gd 3þ in both solutions was quantified by ICP-MS. The encapsulation efficiencies of each resulting Gd 3þ $DOTA3SNPs are summarized in Fig. S1 .
Relaxation measurements
T 1 relaxation rate measurements were performed on a Bruker Avance 600 MHz spectrometer (Bruker BioSpin Corp., Billerica, MA, USA) equipped with a narrowbore (54 mm) 14.1 T magnet and a broadband probe at 295 K. Both inversion recovery (IR) and saturation recovery (SR) pulse sequences were acquired.
Phantom preparation and imaging
For the dilution phantom imaging study, 90 mm capillaries were filled with the diluted solution at concentrations ranging from 4.88 mM to 195 mM and placed together in an 8 mm NMR tube containing D 2 O. Imaging was performed on a Bruker Avance 600 MHz spectrometer (Bruker BioSpin Corp., Billerica, MA, USA) equipped with a Micro 5 gradient system (maximal gradient strength of 192 G/cm in three orthogonal directions). A saturation recovery pulse sequence was used for phantom T 1 -weighted imaging and the magnetization evolved 2.5 s before applying a spin echo pulse sequence to acquire the image.
In vivo imaging
In vivo imaging studies used 4e6 week-old female NOD CB17-Prkd scid / IcrCr1B1tw (NOD/SCID), weighing 25e30 g, obtained from BioLASCO, Taiwan. All animal procedures were in accordance with the regulations approved by the Institution Animal Care and Utilization Committee at National Taiwan University. All the MR data were acquired on a Varian INOVA 7-T NMR spectrometer (Varian Inc., CA, USA) with microimaging capability. The images were obtained using a microimaging 
Results and discussion
The three molecular building blocks, Gd 3þ $DOTA-CD-PEI, Ad-PAMAM, and Ad-PEG (Fig. 1) , were prepared and characterized according to literature [24] Supporting information, Fig. S1 ). A broad spectrum of r 1 emerges from the resulting Gd 3þ $DOTA3SNPs library with r 1 ranging from
. Measurements were performed in water on a 600 MHz NMR spectrometer and are presented in a mesh plot in Fig. 2 . The results highlight an optimal synthetic formulation of Gd 3þ $DOTA3SNPs (1:2 M ratio and 3.9 mM of Gd 3þ ) with a relaxivity of 17.3 s À1 mM À1 (proposed attribution of relaxation enhancement described in Supporting information, Fig. S4 ). We do not measure a difference in Gd 3þ $DOTA3SNPs relaxation between 300 and 600 MHz (results not shown). This is significantly higher than clinical Gd 3þ chelated complexes, i.e., Gd 3þ $DTPA, which has r 1 w4.0 s À1 mM À1 at 300 MHz and 600 MHz. We characterize the resulting Gd 3þ $DOTA3SNPs by measuring the hydrodynamic size of Gd 3þ $DOTA3SNPs with DLS (Fig. 3A) and the results are consistent with TEM images. As shown in Fig. 3B , the TEM images indicate that Gd 3þ $DOTA3SNPs have an average diameter of 103 AE 10 nm with a spherical morphology and narrow size distribution. The hydrodynamic size of Gd 3þ $DOTA3SNPs (124 nm) measured by DLS analysis was larger than the value obtained from TEM, probably due to the swelling of the PEG shell layer on the Gd $DOTA3SNPs is 103 AE 10 nm (Fig. 3C,  left) . The size after 400 times dilution is 112 AE 15 nm (Fig. 3C, center) and in 10% serum is 101 AE 9 nm (Fig. 3C, right) . There are no distinct changes in the average sizes of Gd 3þ $DOTA3SNPs after dilution and in 10% serum; therefore, we conclude that the Gd 3þ $DOTA3SNPs remain stable under these conditions.
To test feasibility of Gd The lymphatic system is a common route for metastatic spread of cancer [28e30] . Dynamic imaging of lymphatic drainage has been regarded as a powerful diagnostic protocol for monitoring cancer metastasis. We attempted to explore the use of Gd 
Conclusion
We have successfully demonstrated the systematic synthesis of a small library of Gd 3þ $DOTA3SNPs by a supramolecular selfassembly approach. The results highlight an optimal synthetic formulation of Gd 3þ $DOTA3SNPs with an r 1 of 17.3 s À1 mM À1 , which is ca. 4-fold higher than clinical Gd 3þ chelated complexes at high field strengths. In addition, the resulting Gd 3þ $DOTA3SNPs
were detected by T 1 -weighted imaging at a concentration of 4.88 mM Gd 3þ with a contrast-to-noise ratio (C/N ratio) of 9.46, ca.
3.6 times greater than the C/N ratio for Gd 3þ $DTPA at the same concentration, signaling a higher sensitivity than conventional MRI CAs. Moreover, the dynamic lymph node drainage MRI demonstrated the applicability of Gd 3þ $DOTA3SNPs in vivo.
